Therapeutic Drug Monitoring
August 8, 2023
Unraveling the potential of therapeutic drug monitoring to empower individual's health
Therapeutic drug monitoring (TDM) is proving to be a powerful tool enabling doctors to tailor dosages of patients while optimizing the treatment outcomes and minimizing the adverse effects of drugs.

Therapeutic drug monitoring is becoming a mainstay of precision medicine by delivering valuable insights into drug interactions, allowing for personalized drug dose adjustments, and improving the efficacy and safety of treatments.

On-site therapeutic drug monitoring is a boon for improving patients' response to the therapies by determining the best dosages for patients taking certain hard-to-dose medicines. Researchers are embarking on clinical trials to assess TDM for patients with inflammatory diseases, cancer, and arthritis, among other medical conditions.

The advent of finger prick tests simplifies therapeutic drug monitoring of biologics while allowing patients to take samples at different intervals remotely. In May 2022, THERADIAG unveiled ez-Track1, a real Point-of-Care Testing (POCT) solution for therapeutic drug monitoring, which gives the results within 10 minutes. The roll-out of these ingenious TDM tests and systems enables rapid decision and definitively accelerates the implementation of biotherapies monitoring.

The incorporation of sensor technologies is underway to offer low-cost, easy-to-use, and on-site analysis methods and to explore the utmost capabilities of therapeutic drug monitoring. Besides, the blending of artificial intelligence (AI) and machine learning (ML) learning algorithms are unleashing remarkable approaches in therapeutic drug management and model-informed precision dosing by providing clinical decision support for precision dosing.